IMPORTANCE Lymph node status is the primary determinant in treatment decision making in early gastric cancer (EGC). Current evaluation methods are not adequate for estimating lymph node metastasis (LNM) in EGC.
1
Currently, endoscopic submucosal dissection (ESD) has become more popular than surgical procedures in treating EGC because it is minimally invasive, preserves function, and results in better quality of life. [2] [3] [4] The principal indication for ESD is a tumor with a low risk of lymph node metastasis (LNM) that can undergo en bloc resection. 3 The incidence of LNM is less than 3% when cancer is limited to the mucosa and increases to approximately 20% after cancer invades the submucosa. 5 Thus, the accurate assessment of nodal status in EGC is integral to providing tailored surgical procedure. 6, 7 So far, the diagnostic accuracy of endoscopic ultrasonography and computed tomography for the nodal status of EGC is limited. 8, 9 Early gastric cancer with undifferentiated histologic result, submucosal invasion, and lymphovascular infiltration is deemed a high risk for LNM, and radical surgical procedure is considered, 3, 5, 10 but a unanimous consensus has not been reached. To estimate the likelihood of LNM for EGC, several studies have developed different prediction models. [11] [12] [13] However, these models focused on the clinical-pathologic characteristics, and the association of the tumor microenvironment with LNM was not investigated. The extracellular matrix constitutes the scaffold of the tumor microenvironment, which regulates cancer behavior. 14 As the main component of the extracellular matrix, collagen accounts for its major functions. The arrangement and orientation of collagen were proven to be indicators of tumor metastasis in breast cancer, 15, 16 glioblastoma 17 and prostate cancer. 18 Nevertheless, the role of collagen in the process of LNM in EGC is still unclear. Multiphoton imaging could provide detailed information about tissue architecture and cell morphology in specimens through a combination of 2-photon excitation fluorescence from cells and second harmonic generation from collagen. 19 Because of the underlying physical origin, multiphoton imaging has emerged as a powerful modality for collagen imaging in diverse tissues. 20, 21 Moreover, multiphoton imaging could be converted into high-dimensional and quantitative components of collagen via automatic extraction of multiple features. Collagen features analysis, including morphologic and textural features extracted from multiphoton imaging, has been applied and demonstrated to be a powerful quantitative indicator for diagnosis in several diseases.
22-24
Integrating multiple biomarkers into a single signature, rather than performing individual biomarker analysis, is a promising approach that would improve clinical management. 25, 26 Currently, an appropriate method of integrating multiple collagen features into a single signature has not yet been developed. Hence, we propose the collagen signature, deduced by multiple morphologic and textural features of collagen using multiphoton imaging. The aim of this study was to develop and validate a prediction model based on the collagen signature that can distinguish genuine highrisk EGC with LNM. To our knowledge, this is the first study to investigate the role of collagen in EGC and to develop a prediction model for LNM based on the fully quantitative collagen signature.
Methods
The institutional review board at each participating center in China (Nanfang Hospital, Guangzhou, Guangdong, People's Republic of China and Fujian Provincial Hospital, Fuzhou, Fujian, People's Republic of China) approved this study. Patient informed consent was waived by the institutional review board because of the retrospective design of the study and patients' information was protected. The study was conducted from August 1, 2016, to May 10, 2018.
Patients and Specimens
The primary cohort (n = 232) was retrospectively assembled using the medical database of Nanfang Hospital. Consecutive patients who received a diagnosis from January 1, 2008, to December 31, 2012 (eFigure 1 in the Supplement) comprised the cohort. The inclusion criteria were patients with histologically confirmed gastric cancer who underwent radical gastrectomy and received a T1 gastric cancer diagnosis after surgical intervention. We excluded patients with neoadjuvant radiotherapy, chemotherapy, or chemoradiotherapy. An additional consecutive cohort (n = 143) who received the same diagnosis at the Fujian Provincial Hospital another hospital from January 1, 2011, to December 31, 2013, and who met the same criteria as the primary cohort was enrolled to provide validation. The formalin-fixed paraffin-embedded specimens of all patients were used. Baseline clinicopathologic data of each patient, including sex, age at surgical intervention, macroscopic classification, tumor location, tumor size, tumor differentiation, lymphovascular infiltration, and depth of invasion, were collected. The tumor differentiation was divided into differentiated and undifferentiated types according to the 2014 Japanese gastric cancer treatment guidelines (version 4). using a microscope at ×200 magnification. The interrater reliability was evaluated (κ = 0.437; 95% CI, 0.295-0.569) with approximately 87.3% (95% CI, 84.3%-90.1%) agreement. When the 2 pathologists differed in opinion, they consulted with the director (G.C.) of the Department of Pathology, Fujian Provincial Cancer Hospital, to make a decision. Five regions of interest with a field of view of 200 × 200 μm per specimen, which were equidistantly spread throughout the invasive margin, were selected to provide a realistic representation of each EGC sample.
Image acquisition for multiphoton imaging was performed with a 200× original magnification objective on another unstained serial section and then compared with hematoxylin-eosin staining for histologic assessment. The multiphoton imaging system used in this study has been described previously (eMethods in the Supplement).
27
The extraction of collagen features was performed using MATLAB 2015b (MathWorks) as previously reported.
28,29 A total of 146 features, including 12 morphologic features and 134 textural features, were extracted (eMethods and eTable 1 in the Supplement).
Feature Selection and Collagen Signature Construction
The LASSO (least-absolute shrinkage and selection operator) logistic regression, which has been broadly applied for highdimensional data, was used to select the most predictive features in the primary cohort. 30 The collagen signature construction was calculated through a combination of selected features (eMethods in the Supplement).
Prediction Model Development and Evaluation
Both the 8 clinicopathologic variables and the collagen signature were included in the univariate analysis to explore the association with LNM in the primary cohort, and variables with P < .05 were selected for the multivariate analysis. Backward stepwise regression was applied to select the independent predictors. The multicollinearity of the multivariate model was assessed using the tolerance and variance inflation factor. In addition, the effect modification was evaluated. A nomogram was constructed according to independent predictors. For quantification of the discrimination of the nomogram, the area under the receiver operating characteristic curve (AU-ROC) was measured. The calibration of the nomogram was evaluated by the calibration curve to assess the goodness of fit, accompanied by the Hosmer-Lemeshow test.
Prediction Model Internal and External Validation
The bootstrap method was applied for internal validation, in which the random samples drawn with a replacement from the original data set were the same size as the primary cohort.
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One thousand bootstrap repetitions were performed. The prediction model was applied in the validation cohort. Ultimately, the AUROC was calculated, and the calibration curve was plotted.
Clinical Application
To evaluate the clinical application of the nomogram, decision curve analysis was used to assess the net benefits of the prediction model at different threshold probabilities (eMethods in the Supplement). 32 The maximum Youden index was selected as the cutoff value to evaluate the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the prediction model.
Statistical Analysis
An independent-samples, unpaired, 2-tailed t test or MannWhitney H test, where appropriate, was used to assess the differences in continuous variables, and a χ 2 test or Fisher exact probability test was used to compare the differences between categorical variables. A multivariate logistic regression was performed to estimate the odds ratio (OR) with a 95% CI and to identify the independent predictors for LNM. Statistical analysis was conducted with R software, version 3.4.2 (R Foundation for Statistical Computing). Differences with a 2-sided P < .05 were considered statistically significant.
Results

Participants
The primary cohort included 232 consecutive patients, in whom the LNM rate was 16 
Collagen Signature Construction
The construction framework of the collagen signature is presented in Figure 1 . All collagen features were reduced to the 6 best potential predictors, using LASSO logistic regression (eFigures 2A and 2B in the Supplement; the 6 features are presented in eAppendix 1 in the Supplement Table 2) . The variance inflation factor of each predictor was less than 10, and the corresponding tolerance was more than 0.1; therefore, no multicollinearity among these predictors was noted (eTable 3 in the Supplement). 33 No effect modification was found in the prediction model (eTables 4 and 5 in the Supplement). The association between the collagen signature and the risk of LNM with different combinations of tumor differentiation states (differentiated or undifferentiated) and depths of tumor invasion (mucosa or submucosa) is presented in eFigure 3 in the Supplement. A nomogram was produced by incorporating these 3 independent predictors ( Figure 2) . The newly developed prediction model showed good discrimination with an AUROC of 0.955 (95% CI, 0.919-0.991), and the calibration curve showed good agreement between the nomogram-estimated probability of LNM and the actual LNM rate in the primary cohort (eFigure 4A and B in the Supplement).
The Hosmer-Lemeshow test demonstrated a P = .47, indicating no departure from a good fit.
Internal and External Prediction Model Validation
For internal validation, we used the bootstrap method with 1000 bootstrap repetitions. The results remained largely unchanged between iterations, with a mean concordance index of 0.911.
Good discrimination with an AUROC of 0.938 (95% CI, 0.897-0.981) was externally validated, and the favorable calibration was also confirmed in the validation cohort (eFigure 4C and D in the Supplement). A Hosmer-Lemeshow test demonstrated a nonsignificant P = .15.
Clinical Application
In the decisive curve, the x-axis is a measure of patient or physician preference, and the threshold probability indicates that the expected advantage of treatment is equal to the expected advantage of avoiding treatment. 33 The decision curve revealed that if the threshold probability of a patient or physician was greater than 5%, more advantages would be added by using the nomogram to estimate LNM in EGC than the advantage achieved in either the treat-all-patient scheme or the treat-none scheme (eFigure 5 in the Supplement). In addition, in the primary cohort, the maximum Youden index of 0.301 was selected as the cutoff value, and the cohort had a sensitivity of 86.8%, a specificity of 93.3%, an accuracy of 92.2%, a positive predictive value of 71.7%, and a negative predictive value of 97.3%. The validation cohort had a sensitivity of 90.0%, a specificity of 90.3%, an accuracy of 90.2%, a positive predictive value of 71.1%, and a negative predictive value of 97.1%. Among the 375 patients, a sensitivity of 87.3%, a specificity of 92.1%, an accuracy of 91.2%, a positive predictive value of 72.1%, and a negative predictive value of 96.9% were found (eTable 6 in the Supplement).
Comparison With the Traditional Prediction Model
To elucidate the superiority of the model we built over the clinicopathologic characteristic-based model (ie, the traditional model), we eliminated the collagen signature and developed the traditional model on the basis of tumor differentiation (OR, 2.576; 95% CI, 1.167-5.685; P = .02), lymphovascular infiltration (OR, 3.333; 95% CI, 1.145-9.703; P = .03), and the depth of tumor invasion (OR, 9.923; 95% CI, 3.305-29.793; P < .001) (eTable 7 in the Supplement) after univariate and multivariate analyses. No multicollinearity in the traditional model was found (eTable 8 in the Supplement). Sex, age at surgical intervention, macroscopic classification, and tumor location were 
Discussion
Accurate assessment of the nodal status in EGC is important in the decision making for lymph node dissection. In this study, we developed and validated a nomogram for individual estimation of LNM in EGC, including the depth of tumor invasion, tumor differentiation, and the collagen signature. Two key factors determine the construction of the collagen signature. The first is the use of a suitable imaging approach to selectively visualize the collagen. In this study, mul- The nomogram indicates the risk of LNM in early gastric cancer. For clinical use, tumor differentiation is determined by drawing a line straight up to the point axis to establish the score associated with the differentiation. Next, this process is repeated for the other 2 covariates (depth of tumor invasion and collagen signature). The scores of each covariate are added, and the total score is located on the total score points axis. Last, a line is drawn straight down to the risk of LNM axis to obtain the probability.
Research Original Investigation
Association of the Collagen Signature With Lymph Node Metastasis in Early Gastric Cancer tiphoton imaging was used because of its underlying physical origin. 20,21 Previous research indicated that multiphoton imaging can distinguish between the mucosa and submucosa of cancerous gastric tissues, and collagen can be quantified by second harmonic generation in a stain-free section. 34 Thus, multiphoton imaging is an ideal method for collagen imaging. The second factor is the quantitative analysis of collagen from multiphoton imaging. For this purpose, we have established a stable framework for achieving precise quantification.
28,29
After considering these 2 factors, we constructed the collagen signature. The collagen signature was substantially different in EGC with and without LNM. To develop a clinically practicable prediction tool, we used other clinicopathologic characteristics. We also built a nomogram with good discrimination and calibration. Our findings suggest that LNM is more likely to appear in patients with an undifferentiated histologic result, submucosal invasion, and a high collagen signature.
Compared with the traditional model based on tumor differentiation, the depth of tumor invasion, and lymphovascular infiltration, the prediction model was more powerful in estimating the risk of LNM in EGC. Although a tumor size larger than 2 cm was statistically significantly associated with LNM, it was excluded after backward stepwise multivariate analysis in both the prediction model and the traditional model. The reason for this exclusion was that the depth of tumor invasion was much more important than tumor size in the clinic.
Currently, endoscopic ultrasonography and computed tomography are the 2 most common examination methods for N staging of gastric cancer. Endoscopic ultrasonography for N staging had a sensitivity of 83% and a specificity of 67%. 35 Meanwhile, computed tomography for detecting LNM had a sensitivity of 78% and a specificity of 62% in gastric cancer. 36 In the prediction model, the sensitivity was 87.3% and the specificity was 92.1%, with the cutoff value of the maximum Youden index. Therefore, the prediction model was adequate for base clinical decisions.
In this study, tumor differentiation and the depth of tumor invasion were categorical variables, and the collagen signature was a continuous variable. The risk of LNM was always contributed to by these 3 predictors. For example, for a patient without LNM with a collagen signature of -2.856, the risk of LNM was less than 1% for differentiated tumors that invaded only the mucosa. When the tumor was undifferentiated, the risk of LNM was approximately 2%, and if the tumor also invaded the submucosa, the risk of LNM increased to 8%. Similarly, for a patient with LNM with a collagen signature of 0.284, the risk of LNM was approximately 30% for differentiated tumors that invaded the mucosa. In the case of undifferentiated tumors, the risk of LNM increased to approximately 70%. Once the tumors invaded the submucosa, the risk of LNM increased to approximately 90%. As tumor differentiation and the depth of tumor invasion are routinely assessed in endoscopic resection specimens, and the collagen signature could be quantified using multiphoton imaging, the individual risk of LNM could be conveniently estimated by the nomogram after ESD. For a low risk of LNM, the nomogram indicates that ESD is adequate. Inversely, for a high risk of LNM, additional lymph node dissection might be needed.
Collagen was identified as a component of cancer metastasis. Local collagen orientations have been shown to play an important role in promoting cell breakage into the basement membrane before entering the circulation systems. 15 Kakkad et al 24 reported that multiphoton imaging revealed that a substantially increased density of collagen was associated with LNM in breast cancer. In our study, the collagen signature was positively correlated with collagen straightness and crosslink density. This result indicated that the collagen arrangement was far straighter in the invasive margin of EGC with LNM. Straighter collagen in the tumor microenvironment could facilitate invasion. 37,38 Meanwhile, increased collagen crosslink density could stiffen the extracellular matrix, enhance growth factor signaling activity, and induce the invasion of an oncogene-initiated epithelium. 39 Our data showed the association between the collagen signature and LNM for EGC. Future studies should focus on the underlying molecular mechanisms.
The collagen features in this study were extracted from multiphoton imaging. Because the components of the multiphoton imaging system were fixed, pathologists could conduct multiphoton imaging using a microscope. Finishing multiphoton imaging took approximately 5 to 10 minutes. Multiphoton imaging was good at showing collagen and did not change the tissue architecture and cell morphology. Therefore, pathologists could understand and analyze multiphoton imaging after training. Meanwhile, the ESD of EGC has no special requirements, and specimens can be processed regularly, which would not affect the multiphoton imaging. Multiphoton imaging is a promising method for realizing realtime in vivo optical biopsy, and several groups have reported the possible clinical applications in different organs. [40] [41] [42] We foresee that clinicians could obtain collagen signature in the near future using multiphoton imaging. With the assistance of the prediction model, EGC with a genuine high risk of LNM would be distinguished, and more tailored surgical interventions could be performed.
Limitations
This study has some limitations. First, because it was a retrospective study, it might result in a potential selection bias. Thus, a multicenter prospective clinical trial is required to confirm the prediction model we developed. We are comfortable with the application of this technique in a clinical trial. Second, the clinicopathologic characteristics between the primary and validation cohorts were similar, which made our validation less robust, and the distribution of clinicopathologic characteristics might be different in other countries. Therefore, cohorts from Western countries are needed to further validate our findings. Third, the sample-size calculation for logistic regression analysis is still debated. We used 2 methods to calculate the sample size: one requires at least 10 events per variable, 43 and the other is based on the variance inflation factor and does not explicitly require knowledge of the number of variables in the regression model. 44 The sample size might not be adequate for the former method but was enough for the latter method (eAppendix 2 in the Supplement). Thus, we hope that this limitation will be solved in our upcoming clinical trial. Fourth, the weak interrater reliability between the 2 pathologists is also a limitation. One pathologist was a senior attending pathologist, and the other was a junior attending pathologist. The weak interrater reliability was the result of the difference in their experiences. In our next trial, we will require 2 senior attending pathologists.
Conclusions
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Collagen feature extraction
The extraction procedure for collagen features has previously been reported by our group.
1
Morphological features
Six morphological features were extracted, namely, the collagen area, length, width, straightness, crosslink density and orientation. The SHG image was first segmented into collagen pixels and background pixels using the Gaussian mixture model method. 2 The binary collagen mask image was then processed using a fiber network extraction algorithm, as described in reference 3, to trace each collagen fiber in the image and to identify cross-link points, which are defined as connecting points between two or more fibers. Moreover, we quantified an orientation index to reflect the collagen alignment based on Fourier-transform spectra.
4
Texture features
For intensity features, a histogram-based approach was used. The mean, variation, skewness, kurtosis, energy and entropy were calculated from the histogram of the SHG pixel intensity distribution.
We also included 80 gray-level co-occurrence matrix (GLCM) 
Least-absolute shrinkage and selection operator (LASSO) binary regression
LASSO binary regression is an effective method for high-dimensional predictors, especially in problems wherein the number of predictors far exceeds the number of observations. 7 The method uses an L1 penalty to shrink the coefficients to zero. The penalty parameter , also called the tuning constant, controls the strength of the penalty. If we reduce and relax the penalty, then more predictors can enter the model. In this study, LASSO binary regression was performed using R (version 3.4.2)
with the "glmnet" package. Five-time cross validations were used to determine the optimal value of .
Finally, the was selected via 1-standard error (SE) criteria.
Construction of the decision curve of the nomogram.
Decision curve analysis (DCA) is a novel tool for assessing the potential population impact of adopting a risk prediction instrument into clinical practice, initially introduced by Vickers and Elkin in 2006. 8, 9 The context for DCA is a situation in which individuals' risks for an undesirable outcome will be assessed, and individuals with sufficiently high risk will be recommended for some intervention or treatment. The DCA provides a net benefit, which is calculated by the following formula:
Net benefit = true-positive rate -false-positive rate * [Pt/(1-Pt)]
Pt is the threshold probability at which the expected benefit of treatment is equal to the expected benefit of avoiding treatment. In this study, Pt indicates the threshold probability of LNM. DCA was plotted using R (version 3.4.2) with the "rmda" package. There were two methods used to calculate the sample size. One was as the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) statement, for which at least 10 events per variable (EPV) were needed. 10 However, as the statement noted, the requirement of 10 EPV was based on two empirical investigations. 11, 12 Some researchers suspected that 10 EPV was too lenient 13 or too strict. 14 Only for a planned prospective prediction model development study would the sample size be predetermined on statistical grounds. 10 The other was based on the variance inflation factor (VIF), which does not explicitly require knowledge of the number of variables in the regression model. 15 The formula was as follows:
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We could take our research as an example to illustrate the formula. The p represents the incidence of LNM in EGC, and B represents when the tumor invaded the submucosa in the proportion of patients in all EGC. The p 0 and p 1 represent the incidence of LNM when the tumor invaded the mucosa and submucosa, respectively. From our data, the incidence of LNM was 3.8% (4/105) and 26.8% (34/127) with mucosa and submucosa invasion, respectively. The incidence of LNM was 16.4% (38/232) and the proportion of submucosa invasion in EGC was 54.7% (127/232). In our multicollinearity assessment, the VIF of the depth of tumor invasion was 1.083. We hypothesized that the type I error was 0.05 and the type II error was 0.1, and the minimum sample size was 110 according to our data.
Our sample size might be not adequate for the TRIPOD method but was enough for the VIF method.
Thus, we hope that this limitation will be solved in our upcoming clinical trial. Fewer studies have been reported for sample size calculation in the validation cohort. Lei et al. 16 revealed that the ratio between primary and validation cohort was 7:3. In our study, the validation cohort contained 143 patients, which 
